Earnings Preview: AptarGroup to Report Financial Results Post-market on May 01
AptarGroup Is Maintained at Outperform by Raymond James
AptarGroup Analyst Ratings
Here's Why Upslope Capital Management Exited Its Stake in AptarGroup (ATR)
Raymond James Maintains AptarGroup(ATR.US) With Buy Rating, Cuts Target Price to $175
AptarGroup's (NYSE:ATR) Investors Will Be Pleased With Their Favorable 36% Return Over the Last Five Years
AptarGroup To Go Ex-Dividend On May 1st, 2025 With 0.45 USD Dividend Per Share
AptarGroup Keeps Quarterly Dividend at $0.45 a Share, Payable May 22 to Holders of Record on May 1
Press Release: Aptar Declares Quarterly Dividend
Will AptarGroup (ATR) Beat Estimates Again in Its Next Earnings Report?
AptarGroup Launching Validation Study of SmartTrack Platform
Aptar Commences Clinical Validation Study Of Its SmartTrack In-Vitro-in-Silico Platform For Pressurized Metered-Dose Inhalers
William Blair Initiates AptarGroup(ATR.US) With Buy Rating
Analysts Conflicted on These Healthcare Names: Outset Medical (OM) and AptarGroup (ATR)
AptarGroup (NYSE:ATR) Hasn't Managed To Accelerate Its Returns
Aptar Named One of Barron's 100 Most Sustainable U.S. Companies for the Seventh Consecutive Year
If EPS Growth Is Important To You, AptarGroup (NYSE:ATR) Presents An Opportunity
Aptar Recognized With Prestigious 'A' Score on the CDP Climate Change Assessment
BofA Picks 36 Stocks to Help Weather Market Downturns
Express News | Aptar Signs Renewable Energy Supply Agreement With Mercuria in Support of Sustainability Goals